This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
CRI and Chordoma Foundation announced today that they have established a research partnership to advance treatment options for chordoma, an ultra-rare cancer in the sarcoma family.
Discussion of the next wave of scientific advancements in immuno-oncology by panel of industry and academic leaders
Five U.S. scientists have been awarded $1.25 million each to carry out high-risk, high-reward cancer immunology research with potential to transform cancer treatment.
30 days of immunotherapy education and awareness programming for patients, caregivers, and the general public celebrating advances in immuno-oncology research and treatment
Cancer Research Institute has published a comprehensive analysis of the current clinical trial landscape of anti PD-1/L1 immune checkpoint inhibitors.
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Staff Directory
This April for Esophageal Cancer Awareness Month, we look at new research, new treatments, and how we’re working toward a future immune to esophageal cancer.
Spring equinox marks a moment of renewal. Why not choose a personal goal to invest in yourself and the world around you? Join ’21 Challenge for Cancer Research.